Cargando…

Performance Verification of CYP2C19 Enzyme Abundance Polymorphism Settings within the Simcyp Simulator v21

Physiologically based pharmacokinetic (PBPK) modeling has a number of applications, including assessing drug–drug interactions (DDIs) in polymorphic populations, and should be iteratively refined as science progresses. The Simcyp Simulator is annually updated and version 21 included updates to hepat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sychterz, Caroline, Gardner, Iain, Chiang, Manting, Rachumallu, Ramakrishna, Neuhoff, Sibylle, Perera, Vidya, Merali, Samira, Schmidt, Brian J., Gaohua, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607610/ https://www.ncbi.nlm.nih.gov/pubmed/36295903 http://dx.doi.org/10.3390/metabo12101001

Ejemplares similares

Prediction of CYP‐mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator
por: Kilford, Peter J., et al.
Publicado: (2022)

Guide to development of compound files for PBPK modeling in the Simcyp population‐based simulator
por: Ezuruike, Udoamaka, et al.
Publicado: (2022)

A Tutorial on Pharmacodynamic Scripting Facility in Simcyp
por: Abduljalil, K, et al.
Publicado: (2016)

SimRFlow: An R-based workflow for automated high-throughput PBPK simulation with the Simcyp(®) simulator
por: Khalidi, Hiba, et al.
Publicado: (2022)

The Simcyp Population Based Simulator: Architecture, Implementation, and Quality Assurance
por: Jamei, Masoud, et al.
Publicado: (2013)

PBPK modeling to predict drug‐drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction
por: Bolleddula, Jayaprakasam, et al.
Publicado: (2021)

In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform
por: Spanakis, Marios, et al.
Publicado: (2014)

Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers
por: Wedagedera, Janak R., et al.
Publicado: (2022)

The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution—A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling
por: Gaohua, Lu, et al.
Publicado: (2023)

Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis
por: Burt, Howard J., et al.
Publicado: (2016)

A perspective on the current use of the phase distribution model for predicting milk‐to‐plasma drug concentration ratio
por: Zhang, Mian, et al.
Publicado: (2022)

Risk–Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling Approach
por: Ezuruike, Udoamaka, et al.
Publicado: (2018)

Overexpression of Golgi Protein CYP21-4s Improves Crop Productivity in Potato and Rice by Increasing the Abundance of Mannosidic Glycoproteins
por: Park, Hyun Ji, et al.
Publicado: (2017)

Evaluation of Memory Enhancing Clinically Available Standardized Extract of Bacopa monniera on P-Glycoprotein and Cytochrome P450 3A in Sprague-Dawley Rats
por: Singh, Rajbir, et al.
Publicado: (2013)

Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder
por: Merali, Samira J., et al.
Publicado: (2023)

Finding abundance regulators
por: Ozguc, Olivia, et al.
Publicado: (2022)

Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera
por: Lao, Qizong, et al.
Publicado: (2023)

Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates
por: Tan, Ming‐Liang, et al.
Publicado: (2018)

A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction
por: Ke, A B, et al.
Publicado: (2012)

Cloning and Functional Verification of CYP408A3 and CYP6CS3 Related to Chlorpyrifos Resistance in the Sogatella furcifera (Horváth) (Hemiptera: Delphacidae)
por: Ruan, Yanwei, et al.
Publicado: (2021)

Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates
por: Haberer, Lynda J., et al.
Publicado: (2013)

Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin
por: Al‐Majdoub, Zubida M., et al.
Publicado: (2020)

Induction and repression effects on CYP and transporter protein abundance by azole mixture uptake in rat liver
por: Hammer, Helen, et al.
Publicado: (2020)

More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter‐Mediated Clearances
por: Emami Riedmaier, Ariane, et al.
Publicado: (2016)

Assessing Potential Drug–Drug Interactions Between Dabigatran Etexilate and a P‐Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling
por: Doki, Kosuke, et al.
Publicado: (2019)

A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form
por: Concolino, Paola, et al.
Publicado: (2009)

Importance of CBCT setup verification for optical‐guided frameless radiosurgery
por: Fu, Lei, et al.
Publicado: (2014)

Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations
por: Neocleous, Vassos, et al.
Publicado: (2014)

Resveratrol inhibits androgen production of human adrenocortical H295R cells by lowering CYP17 and CYP21 expression and activities
por: Marti, Nesa, et al.
Publicado: (2017)

Dual Heterozygous Mutations in CYP21A2 and CYP11B1 in a Case of Nonclassic Congenital Adrenal Hyperplasia
por: Frontera, Eric D., et al.
Publicado: (2022)

Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
por: Kreft, Karim L, et al.
Publicado: (2014)

RAB21 interacts with TMED10 and modulates its localization and abundance
por: Del Olmo, Tomas, et al.
Publicado: (2019)

H62L Mutation of CYP21A2 Identified in the Non-classical Form of 21-Hydroxylase Deficiency
por: Nagasaki, Keisuke, et al.
Publicado: (2009)

Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency
por: Anastasovska, Violeta, et al.
Publicado: (2015)

Data on the 21-Hydroxylase deficient CAH patients and the identification of known/novel mutations in CYP21A2 gene
por: Khajuria, Ragini, et al.
Publicado: (2016)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
por: Bojić, Mirza, et al.
Publicado: (2019)

Verifications
por: Waddell, Flora A.
Publicado: (1887)

Verifications
por: Fornias, Edward
Publicado: (1887)

Verifications
por: Balch, E. T.
Publicado: (1890)

Verifications
por: Guernsey, Wm. Jefferson
Publicado: (1890)

Cannot write session to /tmp/vufind_sessions/sess_avi08kaec144v4ptf3u0b9lbkm